LEI Record LAPSED 549300BYFRN3JS60MY33

Hemispherx Biopharma, Inc.

Policy Non-Conforming

Record as of 2026-10-27

LEI Record Details

  • Entity name

    Hemispherx Biopharma, Inc.

  • Registered At

    Division of Corporations, Department of State
    Division of Corporations, Department of State
    Delaware, United States of America
    RA000602

  • Registered As

    2249636

  • Jurisdiction Of Formation

    US-DE

  • Entity Legal Form

    Corporation (EN)
    XTIQ

  • Entity Status

    ACTIVE

  • Legal Address

    C/O The Prentice-Hall Corporation System, Inc., 2711 Centerville Road, Suite 400, 19808, Wilmington, US-DE, US

  • Headquarters Address

    One Penn Center, 1617 John F. Kennedy Boulevard, Suite 500, 19103, Philadelphia, US-PA, US

Oops! This LEI is Lapsed. An LEI should never be 'Lapsed'. If the entity is no longer trading then the LEI should be marked as 'Retired'. Maintaining an active LEI is widely recommended. Having a Lapsed LEI can also cause complications if the regulator or financial intermediary requires the LEI to be active. A Lapsed LEI can incur penalties such as blocked or delayed trades.

Renew LEI

Registration Details

  • Registration Date

    2016-08-18

  • LEI Issuer

    5493001KJTIIGC8Y1R12

  • Last Update

    2023-08-04

  • Corroboration Level

    FULLY_CORROBORATED

  • Status

    LAPSED

  • Data Validated At

    RA000602

  • Next Renewal

    2017-08-16T20:26:00Z

  • Data Validated As

    2249636

We track third party cookies in order to make the user experience as efficient as possible. Cookies help ensure you get the best experience on our website. By continuing to browse this site, you agree to our use of cookies as described in our Cookie Policy

I Decline Cookies - Limited Features May Apply